Cargando…
Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Liver transplant (LT) is the most favorable treatment option for patients with early stage hepatocellular carcinoma (HCC). Numerous attempts have been pursued to establish eligibility criteria and select HCC patients for LT, leading to various systems that essentially integrate clinico-morphological...
Autores principales: | Gonvers, Stéphanie, Tabrizian, Parissa, Melloul, Emmanuel, Dormond, Olivier, Schwartz, Myron, Demartines, Nicolas, Labgaa, Ismail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9402935/ https://www.ncbi.nlm.nih.gov/pubmed/36033451 http://dx.doi.org/10.3389/fonc.2022.940473 |
Ejemplares similares
-
The Role of Liquid Biopsy in Hepatocellular Carcinoma Prognostication
por: Labgaa, Ismail, et al.
Publicado: (2021) -
Basic Science with Preclinical Models to Investigate and Develop Liquid Biopsy: What Are the Available Data and Is It a Fruitful Approach?
por: Cena, Benedetta, et al.
Publicado: (2022) -
Carcinogenic effect of arsenic in digestive cancers: a systematic review
por: Kasmi, Sophie, et al.
Publicado: (2023) -
Erratum: Is liquid biopsy the future commutator of decision-making in liver transplantation for hepatocellular carcinoma?
Publicado: (2023) -
Experimental Models of Liquid Biopsy in Hepatocellular Carcinoma Reveal Clone‐Dependent Release of Circulating Tumor DNA
por: Labgaa, Ismail, et al.
Publicado: (2021)